BioAdaptives, Inc.
BDPT
$0.07
$0.01629.63%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 0.00 | -- | 700.00 | 12.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 0.00 | -- | 700.00 | 12.00K |
| Cost of Revenue | -- | 0.00 | 60.00K | 21.60K | 8.40K |
| Gross Profit | -- | 0.00 | -60.00K | -20.90K | 3.60K |
| SG&A Expenses | 249.10K | 337.30K | 61.90K | 54.10K | 51.50K |
| Depreciation & Amortization | -- | 0.00 | -- | -- | 1.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 249.10K | 337.30K | 121.90K | 75.70K | 61.80K |
| Operating Income | -249.10K | -337.30K | -121.90K | -75.00K | -49.80K |
| Income Before Tax | -197.10K | -371.80K | -37.60K | -183.00K | -306.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -197.10K | -371.80K | -37.60K | -183.00K | -306.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -197.10K | -371.80K | -37.60K | -183.00K | -306.70K |
| EBIT | -249.10K | -337.30K | -121.90K | -75.00K | -49.80K |
| EBITDA | -248.70K | -337.30K | -121.90K | -75.00K | -47.90K |
| EPS Basic | -0.02 | -0.04 | -0.01 | -0.03 | -0.04 |
| Normalized Basic EPS | -0.01 | -0.02 | 0.00 | -0.02 | -0.02 |
| EPS Diluted | -0.02 | -0.04 | -0.01 | -0.03 | -0.04 |
| Normalized Diluted EPS | -0.01 | -0.02 | 0.00 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 9.05M | 9.91M | 5.97M | 5.97M | 7.70M |
| Average Diluted Shares Outstanding | 9.05M | 9.91M | 5.97M | 5.97M | 7.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |